Key features and details
- Assay type: Competitive
- Detection method: Colorimetric
- Platform: Microplate reader
- Sample type: Cell Lysate, Plasma, Purified protein, Serum, Tissue Lysate
- Sensitivity: 0.5 µg/ml
Overview
Product name
AGE (Advanced Glycation End) Assay Kit
See all AGE kitsDetection method
ColorimetricSample type
Serum, Plasma, Cell Lysate, Purified protein, Tissue LysateAssay type
CompetitiveSensitivity
0.5 µg/mlRange
0.36 µg/ml – 100 µg/mlProduct overview
AGE (Advanced Glycation End Products) Assay Kit (ab238539) is designed for the rapid detection and quantitation of advanced glycation end product protein adducts.
Advanced Glycation End Products (AGE) are formed during the Maillard reaction where reducing carbohydrates react with lysine side chains and N-terminal amino groups of various macromolecules, particularly proteins. The advanced glycation end products can adversely affect the fuction of these macromolecules. One of the most prevalent advanced glycation end products, N-epsilon-(Carboxymethyl) Lysine, has been implicated in oxidative stress and vascular damage. The quantity of AGE adduct in protein samples is determined by comparing its OD with that of a known AGE-BSA standard curve.
Platform
Microplate reader
Properties
Storage instructions
Please refer to protocols.
Components | 96 tests |
---|---|
100X Conjugate Diluent | 1 x 300µl |
10X Wash Buffer | 1 x 100ml |
AGE Conjugate | 1 x 50µl |
AGE-BSA Standard | 1 x 125µl |
Anti-AGE Antibody (1000X) | 1 x 10µl |
Assay Diluent | 1 x 50ml |
Protein Binding Strip Well Plate | 1 unit |
Secondary Antibody, HRP Conjugate (1000X) | 1 x 20µl |
Stop Solution | 1 x 12ml |
Substrate Solution | 1 x 12ml |
Research areas
- Immunology
- Immune System Diseases
- Autoimmune
- Signal Transduction
- Metabolism
- Energy Metabolism
- Cardiovascular
- Atherosclerosis
- Lipoprotein metabolism
- Cardiovascular
- Atherosclerosis
- Diabetes associated
- Cancer
- Cancer Metabolism
- Metabolic signaling pathway
- Metabolism of lipids and lipoproteins
- Cancer
- Cancer Metabolism
- Metabolic signaling pathway
- Integration of energy metabolism
- Metabolism
- Pathways and Processes
- Metabolic signaling pathways
- Lipid and lipoprotein metabolism
- Lipid metabolism
- Metabolism
- Pathways and Processes
- Metabolic signaling pathways
- Lipid and lipoprotein metabolism
- Lipoprotein metabolism
- Metabolism
- Pathways and Processes
- Metabolic signaling pathways
- Energy transfer pathways
- Energy Metabolism
- Metabolism
- Pathways and Processes
- Metabolic signaling pathways
- Energy transfer pathways
- Integration of energy
- Metabolism
- Types of disease
- Diabetes
- Metabolism
- Types of disease
- Heart disease
Relevance
The non enzymatic reaction of reducing carbohydrates with lysine side chains and N terminal amino groups of macromolecules (amino acids, proteins, phospholipids and nucleic acids) is called the Maillard reaction or glycation. The latter products of this process, termed advanced glycation end products (AGEs), adversely affect the functional properties of proteins, lipids and DNA. In long lived tissue proteins, these chemical modifications accumulate with age and may contribute to the pathophysiology of ageing and long term complications of diabetes, atherosclerosis and renal failure.
Cellular localization
Cell Membrane and Secreted
Alternative names
- Advanced glycation end products
- AGEs